ResMed | RMD - 净收入



金融业
股票价格
USD
资产
USD 8.78B
现金及等价物
USD 1.66B
销售成本
USD 551.67M
流动资产
USD 4.06B
流动负债
USD 1.35B
债务
USD 847.72M
股息收益率
1.04
EBIT
USD 505.67M
EBITDA
USD 547.48M
员工
10.6K
EPS每股收益
USD 2.86
股本和储备
USD 6.49B
销售毛利
USD 890.98M
债务利息支出
USD 8.79M
利息收入
USD 59K
贷款资金
USD 404.17M
市值
USD 30.94B
净收入
USD 398.73M
营业费用
USD 925.74M
营业利润
USD 505.67M
普通股股本
USD 190.83M
PE价格收益
21.21
税前利润
USD 496.15M
销售收入
USD 1.4B
销售和管理费用
USD 279.8M
股票
USD 911.88M
贸易债权人
USD 273.3M
应收帐款人
USD 998.84M


净收入 更改 日
Ansell USD 88.8M 65.5M 2025-12
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 108K 1.65M 2026-03
Baxter International USD -15M 1.11B 2026-03
Cochlear AUD 161.5M 69.6M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
CSL USD 401M 96.5M 2025-12
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Fisher Paykel Healthcare NZD 213M 11M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Idexx Laboratories USD 278.45M 30.26M 2026-03
Inogen USD -5.96M 373K 2024-09
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
Masimo USD 57.1M 11.2M 2026-03
Medtronic USD 1.14B 231M 2025-12
Philips EUR 151M 244M 2026-03
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 398.73M 6.14M 2026-03
Sigma Healthcare AUD -6.72M 10.02M 2024-12
Sonic Healthcare AUD 236.68M 82.29M 2024-12
Steris USD 220.3M 27.4M 2026-03
Teleflex USD -8.15M 706.18M 2026-03
Thermo Fisher Scientific USD 1.65B 313M 2026-03